TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

Gryphon Biosciences

private
sign in to save

Gryphon Biosciences is a privately held company tracked for investment-relevant business and technology developments.

sentiment mix
bull 0%bear 0%neu 100%

funding rounds

private markets
awaiting round data

This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.

signal summary

latest high-conviction thesis
Anthropic partners with Gryphon Biosciences for biosecurity red-teaming of frontier models▾

Anthropic engages Gryphon Biosciences, a US government biosecurity contractor, to test whether new models can assist in creating biological weapons — a concrete implementation of its Responsible Scaling Policy.

dario amodeiT2In Good Company with Nicolai Tangen2024-06-26
confidence 78 / 100impact High
key themes
  • Frontier AI Models100%
  • AI Safety & Alignment100%
  • AI Interpretability100%
  • AI Drug Discovery100%
  • AI Hardware & Chip Architecture100%

bull thesis · 0

—
  • — none —

bear thesis · 0

—
  • — none —

mentions · 1

In Good Company with Nicolai TangenDario Amodei - CEO of Anthropic | Podcast | In Good Company | Norges Bank Investment Management1 mentions · 0▲ 0▼ 1○ · 2 years ago
0:007:0015:0022:0030:00